Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study.

ABSTRACT:

Objectives

The objective of this study is to assess the cost utility of the implementation of the human papillomavirus (HPV) vaccination programme in Tunisia in addition to the current cytology screening strategy. This study is very important to guide health policy decision-makers and to help them allocate their scarce healthcare resources.

Design

We used a previously described Markov model on the Online Cost Effectiveness Analysis tool programmed with R Software. The Markov cohort model was used to simulate the natural history of HPV infection and cervical cancer for a cohort of 100 000 females aged from 10 to 84 years. The model was calibrated with Tunisian parameters to calculate the long-term health benefits and costs of different cervical cancer preventive strategies in

SUBMITTER: Khiari H 

PROVIDER: S-EPMC11624740 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature